HARP — Harpoon Therapeutics Share News
0.000.00%
Last trade - 00:00- $492.35m
- $469.57m
- $31.92m
U.S. RESEARCH ROUNDUP-Axonics, BlackRock, Credit Acceptance
U.S. STOCKS ON THE MOVE-Core & Main, Commercial Metals, Equifax
U.S. STOCKS ON THE MOVE-Toll Brothers, American Eagle Outfitters, Twilio
Wrapup 1: Drugmakers kick off industry conference with two cancer deals
U.S. STOCKS ON THE MOVE-Moderna, Coinbase, Ambrx Biopharma
Merck to buy Harpoon Therapeutics for $680 million (updated)
Merck to buy Harpoon Therapeutics for $680 million
U.S. STOCKS ON THE MOVE-DoorDash, Harpoon Therapeutics, Heron Therapeutics
Deals of the day-Mergers and acquisitions
Harpoon Therapeutics surges after Merck's buyout report
Merck in talks to buy Harpoon Therapeutics for around $700 mln - Bloomberg News
Brief: Merck Is In Advanced Talks To Buy Harpoon Therapeutics- Bloomberg News
Brief: Harpoon Therapeutics Files For Secondary Offering Of Up To 25.8 Million Shares Of Common Stock
Brief: Harpoon Therapeutics- Entered Into Sales Agreement, May Offer, Sell Shares Of Common Stock For Offering Price Of Up To $75 Million From Time To Time
Brief: Ra Capital Management Lp Reports 9.99% Passive Stake In Harpoon Therapeutics Inc As Of Oct 26 - SEC Filing
U.S. RESEARCH ROUNDUP-Amgen, Fiserv, Visa
U.S. RESEARCH ROUNDUP-American Express, Braze, Engagesmart
U.S. STOCKS ON THE MOVE-LumiraDx, Navios Maritime, Spirit AeroSystems
U.S. STOCKS ON THE MOVE-Alcoa, Harpoon, EngageSmart